Literature DB >> 9300065

Acute exacerbation of multiple sclerosis increases plasma levels of S-100 protein.

U Missler1, K P Wandinger, M Wiesmann, M Kaps, K Wessel.   

Abstract

OBJECTIVES: To determine whether an increase in plasma concentration of S-100 protein can serve as a marker for acute exacerbation of multiple sclerosis.
MATERIAL AND METHODS: The plasma level of S-100 protein was investigated in 28 patients suffering from multiple sclerosis. Of these, 17 patients were admitted for acute exacerbation and 11 patients had a stable disease with no clinical signs for acute exacerbation. S-100 protein concentrations in plasma were determined with an immunofluorometric sandwich assay.
RESULTS: Plasma concentrations were significantly elevated in patients who were examined within 7 days after the onset of acute exacerbation (n = 6). S-100 levels of patients 8 to 28 days after the onset of acute exacerbation (n = 11) did not differ from healthy controls (n = 120). Eleven patients with multiple sclerosis without acute exacerbation had moderately elevated plasma levels.
CONCLUSION: The plasma concentration of S-100 protein is a sensitive although unspecific indicator of neuronal damage and may be of use as a marker of disease activity in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300065     DOI: 10.1111/j.1600-0404.1997.tb00256.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.

Authors:  J Steiner; H Bielau; H-G Bernstein; B Bogerts; M T Wunderlich
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

Review 2.  Current and Future Biomarkers in Multiple Sclerosis.

Authors:  Jennifer Yang; Maysa Hamade; Qi Wu; Qin Wang; Robert Axtell; Shailendra Giri; Yang Mao-Draayer
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

3.  S-100beta protein--serum levels in children with brain neoplasms and its potential as a tumor marker.

Authors:  Anil Rajendra; Philip C Spinella; Henry R Drott; Troy E Dominguez; Leslie Sutton; Mark Helfaer
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.